Clinical trial · Observational
"FU-IFM2009" Database Post IFM/DFCI 2009 Study
"Follow Up-Intergroupe Francophone du Myélome 2009" Database Post IFM/DFCI 2009 Study
NCT03679351CI-TRIAL-00046286DB-FU-IFM2009unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Extension of patient follow-up of the IFM/DFCI 2009 study over a period of 4 years (that is, from 01 December 2016 to 30 November 2020) during which patients will be followed up in the normal course of care and according to the usual care of the centers, with collection of the needed data about twice a year by the investigators
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- progression free survival
- timeFrame
- 4 years
- description
- number of deaths
Secondary outcomes (2)
- measure
- overall long-term survival
- timeFrame
- 4 years
- description
- number of deaths
- measure
- secondary primary malignancies
- timeFrame
- 4 years
- description
- number of secondary primary malignancies
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Patient randomized in the IFM/DFCI 2009 study. * Patient still alive must give their non-opposition to the post IFM/DFCI 2009 study data collection until 30 November 2020 * Patient non-opposition.
References
Publications (0)
Data not yet available
No reference posted for this study.